Certificate under Regulation 7(3) for the Half Year Ended March 31, 2018

Statement of Investor Complaints for the quarter ended March 31, 2018

Update on Additional Investment - MYR 50,000 in Advanced Enzymes (Malaysia) Sdn. Bhd. Subsidiary.

Intimation of FE CFO Awards 2018

Update on Additional Investment of MYR 150,000 In Advanced Enzyme (Malaysia) Sdn. Bhd., Subsidiary.

Statement of Investor Complaints for the Quarter ended December 31, 2017

Compliance under Regulation 7(3) for the half year ended on September 30, 2017

Statement of Investor Complaints for the Quarter ended September 30, 2017.

Update on acquisition of evoxx technologies GmbH (Evoxx)

Intimation Notice and Annual Report FY 2016-17

Press Release dated July 27, 2017

Intimation of acquisition of evoxx technologies GmbH by Wholly Owned Subsidiary Company

Update on Incorporation of Wholly owned Subsidiary in Netherlands.

Statement of Investor Complaints for Quarter Ended June 30, 2017

Intimation of Change of Name of the Company's Subsidiary

Updation on Acquisition of Palm Techno Ventures Enzyme Sdn Bhd, Malaysia

Intimation of Award dated June 2, 2017

Update on acquisition of Palm Techno Ventures Enzyme Sdn Bhd, Malaysia

Intimation of Dividend Recommended

Intimation of Record Date - BSE

Intimation of Record Date - NSE

Intimation of Acquisition approved on April 22, 2017

Statement of Investor Compliant Q4

Intimation on ESOP and Sub - Division.

Intimation of Grant of ESOS

Intimation of Publication of Unadited Financial Results for Quarter ended December 2016

Change In KMP

Statement of Investor Compliant - Q3

Intimation of Acquisition dated on 01.12.2016

Compliance Certificate under Regulation 7(3)

Intimation of Publication of Unaudited Financial Results.

Intimation of Acquisition

Statement of Investor Compliant-Q2